To explore the association between the levels of UFM1 and UFSP2 and pathological AD markers, we next obtained published data from the biochemical quantification of apoE, Aβ40, Aβ42, tau, and pT231-tau of sequential fractions of the temporal cortex from the same AD cases [32]. The gene discussed is MAPT; the disease is Alzheimer disease.